These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31123053)

  • 1. Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.
    Hu S; Huang KM; Adams EJ; Loprinzi CL; Lustberg MB
    Clin Cancer Res; 2019 Nov; 25(21):6295-6301. PubMed ID: 31123053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
    Kachrani R; Santana A; Rogala B; Pawasauskas J
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
    J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
    Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
    Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
    Mansooralavi N; Khomula EV; Levine JD
    Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
    Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.
    Chow R; Novosel M; So OW; Bellampalli S; Xiang J; Boldt G; Winquist E; Lock M; Lustberg M; Prsic E
    BMJ Support Palliat Care; 2023 Mar; 13(1):27-34. PubMed ID: 36194493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy-induced peripheral neuropathy and neuropathic pain].
    Schuler U; Heller S
    Schmerz; 2017 Aug; 31(4):413-425. PubMed ID: 28293734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the usefulness of duloxetine for chemotherapy-induced peripheral neuropathy.
    Kanbayashi Y; Inagaki M; Ueno H; Hosokawa T
    Med Oncol; 2017 Aug; 34(8):137. PubMed ID: 28687964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.
    Battaglini E; Park SB; Barnes EH; Goldstein D
    Contemp Clin Trials; 2018 Jul; 70():135-138. PubMed ID: 29680317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
    Selvy M; Pereira B; Kerckhove N; Busserolles J; Farsi F; Guastella V; Merle P; Pezet D; Balayssac D
    Support Care Cancer; 2021 Jul; 29(7):4033-4043. PubMed ID: 33403401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
    Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
    Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.
    Dorsey SG; Kleckner IR; Barton D; Mustian K; O'Mara A; St Germain D; Cavaletti G; Danhauer SC; Hershman DL; Hohmann AG; Hoke A; Hopkins JO; Kelly KP; Loprinzi CL; McLeod HL; Mohile S; Paice J; Rowland JH; Salvemini D; Segal RA; Smith EL; Stevens WM; Janelsins MC
    J Natl Cancer Inst; 2019 Jun; 111(6):531-537. PubMed ID: 30715378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
    Hirayama Y; Yoshida Y; Mori M; Tamura K
    Jpn J Clin Oncol; 2020 Aug; 50(8):897-902. PubMed ID: 32424420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H
    Fukushima J Med Sci; 2022 Apr; 68(1):1-10. PubMed ID: 35197393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Kuriyama A; Endo K
    Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
    Gewandter JS; Kleckner AS; Marshall JH; Brown JS; Curtis LH; Bautista J; Dworkin RH; Kleckner IR; Kolb N; Mohile SG; Mustian KM
    Support Care Cancer; 2020 Jun; 28(6):2553-2562. PubMed ID: 31494735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced neuropathy.
    Bhagra A; Rao RD
    Curr Oncol Rep; 2007 Jul; 9(4):290-9. PubMed ID: 17588354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and Nonpharmacological Management of Chemotherapy-Induced Peripheral Neuropathy: A Scoping Review of Randomized Controlled Trials.
    Jones KF; Wechsler S; Zulewski D; Wood L
    J Palliat Med; 2022 Jun; 25(6):964-995. PubMed ID: 35128938
    [No Abstract]   [Full Text] [Related]  

  • 20. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
    Chu SH; Lee YJ; Lee ES; Geng Y; Wang XS; Cleeland CS
    Support Care Cancer; 2015 Feb; 23(2):513-24. PubMed ID: 25256375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.